Search
News & Events
Aboriginal families at the heart of BHP’s $20m Telethon pledgeBHP has announced a $20 million commitment to Telethon over the next five years to fund a world-first research partnership with Aboriginal families in the Pilbara and Perth.
News & Events
Computational research helps boost rare disease diagnosisResearchers at The Kids Research Institute Australia working to provide confident diagnoses for children suffering from rare diseases have created a new computer algorithm to help pinpoint the mutations responsible for the conditions.
News & Events
International COVID-19 ‘risk’ tool launched to reduce community transmissionThe Kids Research Institute Australia researchers have collaborated with global experts to launch an online tool designed to assess the risk of contracting COVID-19 and provide advice to reduce transmission.
There are lots of ways of getting involved in the research at the Wesfarmers Centre.
Philanthropically-minded members of the community are lending their support to The Kids Research Institute Australia’s up-and-comers.
Bright Blue The Police Commissioner's Fund for Sick Kids has generously outfitted the The Kids brain tumour lab with a cancer analysis suite.
ORIGINS is fortunate to have a small passionate and dedicated group of longstanding volunteers.
News & Events
Return to school measures build confidenceWA parents and carers can have confidence in sending their children back to school on January 31 with the measures outlined in today’s Safe Return to School Plan.
News & Events
Infectious diseases advocate and child disability researcher named as finalists for national awardsCongratulations to prominent consumer advocate Catherine Hughes and The Kids Research Institute Australia honorary researcher Dr Noula Gibson, who have been named finalists in Research Australia’s 2023 Health and Medical Research Awards.
News & Events
WA partnership to unlock new antibiotic weaponThe Kids Research Institute Australia and WA pharmaceuticals company Boulos and Cooper have signed a $685,000 agreement to develop what could be the first new class of antibiotics in decades.